Ocular Therapeutix: 4Q Earnings Snapshot
BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Thursday reported a loss of $26 million in its fourth quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 53 cents. Losses, adjusted for non-recurring costs, came to 47 cents per share.
The biotechnology company posted revenue of $2.3 million in the period.
For the year, the company reported that its loss widened to $86.4 million, or $1.91 per share. Revenue was reported as $4.2 million.
In the final minutes of trading on Thursday, the company’s shares hit $4.29. A year ago, they were trading at $4.36.